Clinical Trials Directory

Trials / Completed

CompletedNCT00446940

Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
Bader, Ted, M.D. · Individual
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Different Doses of rosuvastatin and atorvastatin will be used to see if HCV viral load changes and liver tests change.

Conditions

Interventions

TypeNameDescription
DRUGrosuvastatin
DRUGatorvastatin

Timeline

Start date
2006-12-01
Completion
2007-03-01
First posted
2007-03-13
Last updated
2008-09-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00446940. Inclusion in this directory is not an endorsement.